Pauline Bourst
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Pauline Bourst has a total of 8 co-authors. Here are the top co-authors by number of shared publications:
- Aurélie Bannay
Université de Lorraine, Centre Hospitalier Régional Universitaire de Nancy, Centre national de la recherche scientifique, Inria, Laboratoire lorrain de recherche en informatique et ses applications, Nancy, France
1 shared publication Bruno Levy
Medical Intensive Care Unit, CHRU-Nancy, Brabois Hospital, Université de Lorraine, Nancy, France
1 shared publication- Caroline Ziegler
Service d’Hématologie Clinique, Hôpital Brabois, Centre Hospitalier Regional Universitaire de Nancy, 54500 Vandoeuvre les Nancy, France
1 shared publication - Gérard Audibert
Anesthesiology Department, CHRU Nancy, France
1 shared publication - Marie-Reine Losser
Unité de réanimation, D.A.R. Hôpital Lariboisière. 75010 Paris
1 shared publication - Olivier Ziegler
Inserm UMR 1256 NGERE (Nutrition-Genetics-Environmental Risks), Department of Endocrinology Diabetology and Nutrition, CHRU-Nancy, University of Lorraine, F-54000 Nancy, France
1 shared publication
Latest Publications
- 10 June 2021
- Published by Springer Nature in International Journal of Obesity
- Vol. 45 (9) , 2028-2037
Obesity and mortality in critically ill COVID-19 patients with respiratory failure
Background Patients with obesity are at increased risk of severe COVID-19, requiring mechanical ventilation due to acute respiratory failure. However, conflicting data are obtained for intensive care unit (ICU) mortality. Objective To analyze the relationship between obesity and in-hospital mortality of ICU patients with COVID-19. Subjects/methods Patients admitted to the ICU for COVID-19 acute respiratory distress syndrome (ARDS) were included retrospectively. The following data were collected: comorbidities, body mass index (BMI), the severity of ARDS assessed with PaO2/FiO2 (P/F) ratios, disease severity measured by the Simplified Acute Physiology Score II (SAPS II), management and outcomes. Results For a total of 222 patients, there were 34 patients (15.3%) with normal BMI, 92 patients (41.4%) who were overweight, 80 patients (36%) with moderate obesity (BMI:30–39.9 kg/m2), and 16 patients (7.2%) with severe obesity (BMI ≥ 40 kg/m2). Overall in-hospital mortality was 20.3%. Patients with moderate obesity had a lower mortality rate (13.8%) than patients with normal weight, overweight or severe obesity (17.6%, 21.7%, and 50%, respectively; P = 0.011. Logistic regression showed that patients with a BMI ≤ 29 kg/m2 (odds ratio [OR] 3.64, 95% CI 1.38–9.60) and those with a BMI > 39 kg/m2 (OR 10.04, 95% CI 2.45–41.09) had a higher risk of mortality than those with a BMI from 29 to 39 kg/m2. The number of comorbidities (≥2), SAPS II score, and P/F < 100 mmHg were also independent predictors for in-hospital mortality. Conclusions COVID-19 patients admitted to the ICU with moderate obesity had a lower risk of death than the other patients, suggesting a possible obesity paradox.
- 10 June 2021
- Published by Springer Nature in International Journal of Obesity
- Vol. 45 (9) , 2028-2037
Obesity and mortality in critically ill COVID-19 patients with respiratory failure
Background Patients with obesity are at increased risk of severe COVID-19, requiring mechanical ventilation due to acute respiratory failure. However, conflicting data are obtained for intensive care unit (ICU) mortality. Objective To analyze the relationship between obesity and in-hospital mortality of ICU patients with COVID-19. Subjects/methods Patients admitted to the ICU for COVID-19 acute respiratory distress syndrome (ARDS) were included retrospectively. The following data were collected: comorbidities, body mass index (BMI), the severity of ARDS assessed with PaO2/FiO2 (P/F) ratios, disease severity measured by the Simplified Acute Physiology Score II (SAPS II), management and outcomes. Results For a total of 222 patients, there were 34 patients (15.3%) with normal BMI, 92 patients (41.4%) who were overweight, 80 patients (36%) with moderate obesity (BMI:30–39.9 kg/m2), and 16 patients (7.2%) with severe obesity (BMI ≥ 40 kg/m2). Overall in-hospital mortality was 20.3%. Patients with moderate obesity had a lower mortality rate (13.8%) than patients with normal weight, overweight or severe obesity (17.6%, 21.7%, and 50%, respectively; P = 0.011. Logistic regression showed that patients with a BMI ≤ 29 kg/m2 (odds ratio [OR] 3.64, 95% CI 1.38–9.60) and those with a BMI > 39 kg/m2 (OR 10.04, 95% CI 2.45–41.09) had a higher risk of mortality than those with a BMI from 29 to 39 kg/m2. The number of comorbidities (≥2), SAPS II score, and P/F < 100 mmHg were also independent predictors for in-hospital mortality. Conclusions COVID-19 patients admitted to the ICU with moderate obesity had a lower risk of death than the other patients, suggesting a possible obesity paradox.